Skip to main content
Log in

Real-time continuous glucose monitoring device cost effective in UK

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2018 British pounds (GBP)

Reference

  • Roze S, et al. Long-term Cost-Effectiveness of Dexcom G6 Real-Time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Patients With Type 1 Diabetes in the U.K. Diabetes Care : 9 Jul 2020. Available from: URL: http://doi.org/10.2337/dc19-2213

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Real-time continuous glucose monitoring device cost effective in UK. PharmacoEcon Outcomes News 858, 28 (2020). https://doi.org/10.1007/s40274-020-7001-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7001-4

Navigation